Coronary blood flow is dependent on multiple physiological factors that affect force generation by coronary vascular smooth muscle cells (VSMCs). These factors include intrinsic response of VSMCs to intravascular pressure (the vascular myogenic response) and release of vasoactive metabolites
T he principal function of the coronary circulation is to deliver oxygen and energetic substrates to the myocardium to match myocardial demand for oxygen and energy with the proper supply under various physiological conditions. Oxygen extraction in the coronary circulation is 75% to 80% under baseline physiological conditions, leaving little oxygen extraction reserve. Because this extraction is near maximum to increase oxygen delivery, further extraction is not a viable option, 1, 2 which necessitates that an increase in myocardial work be met, nearly instantaneously, by an increase in coronary flow to maintain an adequate oxygen supply. Imbalance of myocardial oxygen supply-to-demand ratio results in a deterioration of myocardial function within a few seconds. 3 The tight matching of oxygen supply and demand must be guaranteed by local flow regulatory mechanism in any condition to avoid pump failure. from cell types, including endothelium, nerves, and cardiomyocytes. [4] [5] [6] [7] The tone of vascular smooth muscle is largely regulated by the membrane potential, which controls the amount of calcium in the sarcoplasm via the voltage-gated calcium channels. Membrane hyperpolarization through the opening of potassium channels in VSMCs reduces activation of voltagegated calcium channels, leading to reduction of Ca 2+ entry and vasodilatation. In contrast, closure of K + channels leads to membrane depolarization and causes vasoconstriction. [8] [9] [10] Four major classes of potassium channels have been identified in VSMCs: adenosine triphosphate (ATP)-sensitive (K ATP ) potassium channels, inward rectifier (Kir) potassium channels, large conductance Ca 2+ -activated (BK) potassium channels, and voltage-dependent potassium (Kv) channels. 8, 9, [11] [12] [13] [14] [15] [16] Of these channel families, our previous results have suggested that the Kv family is involved in coronary metabolic flow regulation, 17 in a scheme where production of hydrogen peroxide (H 2 O 2 ) from mitochondria produces opening of the channels and, thus, dilation in a feed-forward manner. 18 We also found that H 2 O 2induced redox-sensitive coronary vasodilatation 19 is mediated by 4-aminopyridine-sensitive K + channels. 17 However, it is important to recognize that the use of a pharmacological antagonist does not irrefutably test for a specific ion channel because drugs, such as 4-aminopyridine, can antagonize other classes of ion channels, for example, K ATP . 20 Moreover, the Kv channel family is large, with 12 families of channels and multiple channels in each family. Thus, the precise ion channel(s) linking the products of metabolism to coronary blood flow is (are) unknown.
Although several types of Kv family channels are expressed in various cells in the heart, we focused on Kv1.5 channels, which are reported to be oxygen-and redox-sensitive and expressed in VSMCs. [21] [22] [23] These results, when taken together with our previous observations, [17] [18] [19] provoked us to hypothesize that Kv1.5 channels play a critical role in the coupling of myocardial blood flow (MBF) to cardiac work (CW). Accordingly, we studied coronary metabolic dilation (changes in MBF in response to increases in CW, ie, the connection of coronary blood flow to myocardial metabolism) in wild-type (WT) mice, mice null for Kv1.5 channels (Kv1.5 −/− ), and mice with inducible, smooth muscle-specific expression of Kv1.5 channels (on Kv1.5 −/− and WT backgrounds). We also measured tissue oxygenation to understand whether the balance between oxygen supply (product of blood flow and oxygen content) and CW, which is a surrogate for myocardial oxygen consumption, was altered in the genetically modified animals. Our results support a new concept, vis-à-vis, that Kv1.5 channels play a critical role in connecting blood flow to metabolism in the myocardium.
Methods
A detailed description of the methodologies, protocols, and statistical analyses are presented in the Online Data Supplement. The murine models are described later.
All procedures were conducted with the approval of the Institutional Animal Care and Use Committee of the Northeastern Ohio Medical University and Department of Radiology and Medicine, Geisel School of Medicine at Dartmouth College, and in accordance with National Institutes of Health Guidelines for the Care and Use of Laboratory Animals (National Institutes of Health publication no. 85-23, revised 1996). Mice were housed in a temperature-controlled room with a 12:12-h light/dark cycle and maintained with access to food and water ad libitum.
Murine Models
WT mice (C57Bl/6N and S129) and mice of both backgrounds that were null for the KCNA5 gene, which encodes Kv1.5 channels (Kv1.5 −/− ), were used in this study. 24 Kv1.5 −/− mice on a S129 background were a gift of Helmut Kettenmann (Max Delbrueck Center for Molecular Medicine, Berlin). These mice were backcrossed into a C57Bl/6N background (>6 generations) to obtain C57Bl/6N null for KCNA5.
Generation of Inducible Double Transgenic Mouse With Smooth Muscle-Specific Expression of Kv1.5 Channels
Transgenic mice with smooth muscle-specific expression (SM22-α promoter) of the reverse tetracycline transactivator gene (rtTA), SM22-rtTA, were purchased from Jackson Laboratory (Figure 1 ). Transgenic mice expressing Td-Tomato and Kv1.5 channel with tet-on expression were made by pronuclear injection of DNA construct of Tet-On 3G tetracycline-inducible system (Clontech) with insertion of Td-Tomato and mouse Kv1.5 cDNA in an IRES (internal ribosome entry site) construct. After screening, the founders expressing Kv1.5 channels and Td-tomato were crossed with the SM22-rtTA mice to produce double transgenic mice (SM-22-tet-Kv1.5). Double transgenic mice have copies of each transgene in all cells, but without tetracycline, the genes are not expressed. In the presence of doxycycline, the Kv1.5 and Td-Tomato gene are transcribed in smooth muscle. In this model, 7 to 10 days of doxycycline treatment (2 mg/mL in drinking water) will induce expression of Kv1.5 channels and Td-Tomato only in smooth muscle.
Smooth Muscle-Specific Rescue: Expression of Kv1.5 in Smooth Muscle in KV1.5 −/−
To determine whether expression of Kv1.5 channels in smooth muscle is critical for coronary flow regulation during changes in CW, we determined whether expression of Kv1.5 channels in smooth muscle would rescue the phenotype observed in the global Kv1.5 knockout mice. To accomplish this, double transgenic mice (SM-22-tet-Kv1.5) were crossed with Kv1.5 null mice to create a mouse with reconstituted (RC) doxycycline-inducible expression of Kv1.5 channels in smooth muscle in Kv1.5 −/− mice, namely SM-Kv1.5 RC ( Figure 1 ).
We studied 4 groups of 4-to 5-month-old mice: Kv1.5 −/− (N=15), WT (N=15), double transgenic (SM-22-tet-Kv1.5, N=15), and reconstituted smooth muscle-specific Kv1.5 expression on the null background (SM-Kv1.5 RC, N=15). calculated. It is also worth noting that differences in cardiac function (EF and fractional shortening) between WT and Kv1.5 −/− were apparent at all doses of norepinephrine (Online Figure I ). During norepinephrine infusion, EF was significantly lower at all time points in Kv1.5 −/− mice compared with WT mice ( Figure 2B ). In the double transgenic mice on the Kv1.5 −/− background, with 7 to 10 days of doxycycline treatment to induce smooth muscle expression of Kv1.5 channels, cardiac function (EF) was increased by norepinephrine to levels comparable to those of WT mice (P=NS) and significantly greater than those of Kv1.5 −/− mice (P<0.05). The time course of changes in systolic arterial pressure in WT ( Figure 2C ) and Kv1.5 −/− ( Figure 2D ) mice show a striking difference. In WT mice, during the highest dose of norepinephrine, blood pressure increased to a steady-state level and dropped only after the norepinephrine infusion was stopped.
Results

Cardiac Function and Hemodynamics
In contrast, Kv1.5 −/− mice maintained arterial pressure only transiently, for ≈30 s, during infusion of norepinephrine, then the pressure dropped. If the norepinephrine infusion was not stopped, mortality ensued in the null mice. Figure 2E illustrates the effects of norepinephrine on arterial systolic pressure in the Kv1.5 −/− -RC mice treated with doxycycline to induce smooth muscle-specific expression of Kv1.5 channels. These mice, like WT mice, had a steady-state increase in arterial pressure to norepinephrine infusion, which fell only when the infusion was stopped. To obtain measurements of MBF, we used the 30-s period when pressure was elevated as a quasi-steady state to obtain flow and work measurements during high-dose norepinephrine (5 μg/kg per minute). At baseline, mean arterial pressure was significantly higher in Kv1.5 −/− mice. After 7 days of treatment with doxycycline, the blood pressure dropped significantly in Kv1.5 −/− -RC and WT-RC mice. Mean arterial pressure, heart rate, and CW was not significantly different between WT and Kv1.5 −/− -RC mice after treatment with doxycycline (Online Figure I ). Left ventricular (LV) mass in Kv1.5 −/− mice was significantly higher compared to WT mice, but after doxycycline treatment in Kv1.5 −/− -RC mice, LV mass was not significantly different than that of WT mice (Online Figure II ). There were no significant differences in body weight among all 4 groups of mice. The relationships between MBF and the double product (DP) for the 3 groups are shown in Figure 3 . MBF in Kv1.5 −/− mice was significantly (P<0.05) lower at any given DP than that in either WT or the transgenic (Kv1.5 −/− -RC) mice after doxycycline treatment. In Kv1.5 −/− mice at baseline and at any given dose of norepinephrine, the mean arterial pressure was higher compared with that in WT and Kv1.5 −/− -RC mice, which shifted the DP line to the right. In transgenic mice (Kv1.5 −/− -RC), re-expression of Kv1.5 channels in smooth muscle, by administering doxycycline for 7 days, re-established the connection between MBF and oxygen demands as indicated by DP. Treatment of the Kv1.5 −/− -RC with doxycycline increased expression of mRNA level of Kv1.5 channel in the aorta ≈8fold (Online Figure III) . Doxycycline alone does not change the Kv1.5 channel expression in null mice or in WT mice, but in WT mice, with the 2 transgenes, increased expression of Kv1.5 channels shifted the relationship between DP and MBF to the left (Online Figure IV) . This resulted in the observation that for any workload, MBF in the WT-RC animals was greater than in WT animals (P<0.05). We also analyzed MBF against CW (Online Figure V) to ascertain whether this relationship provided different insights than the plot of MBF versus DP; our conclusions were unchanged in that mice null for Kv1.5 channels had compromised increases in flow during enhanced metabolic demands depicted by either DP or CW.
Sometimes the deletion of a specific gene in one genetic background (in mice) leads to a different result than if the deletion is in another background. To determine whether the background of the mice makes a difference in the relationships between work and flow in the heart, we compared these variables in WT and Kv1.5 −/− mice of C57Bl/6N and S129 mice (Online Figure VI) . The results indicated that background did not influence our findings. The responses in the WT mice were comparable, and the deletion of Kv1.5 channels showed similar compromised metabolic dilation in both strains. We also would like to add that expression of other ion channels was altered in Kv1.5 −/− mice. In particular, we noted that expression of Kv1.2, Kir6.1, and Kir6.2 channels was upregulated (mRNA measured by real-time polymerase chain reaction), Kv1.3 and Kv7.1 appeared to be downregulated, and Kv2.1 was not altered (Online Figure VII) .
To determine whether the imbalance between metabolism and flow, that is, insufficient coronary blood flow to meet cardiac metabolic demands, resulted in tissue hypoxia, we measured myocardial tissue oxygenation. Myocardial oxygen tension (PO 2 ) was significantly (P<0.05) lower in Kv1.5 −/− mice compared with WT mice at baseline and any time point after high dose of norepinephrine injection ( Figure 4 ). We also used hypoxyprobe-1 to identify hypoxic regions in the myocardium. As shown in Online Figure VIII, augmented metabolic demands induced by norepinephrine infusion increased myocardial tissue hypoxia in Kv1.5 −/− (as indicated by higher signal intensities for the fluorescence) more than in WT mice. The average signal intensity from the ischemic zone was significantly higher in Kv1.5 −/− mice compared with WT mice (P<0.05 compared with WT). In Kv1.5 −/− -RC mice after 7 days of doxycycline treatment, the hypoxic areas were significantly less intense compared with that in Kv1.5 −/− mice. It is important to note the re-expression of the Kv1.5 channels in smooth muscle minimized tissue hypoxia, that is, the fluorescent signals were comparable to those of controls. Figure 5 illustrates vasodilatory responses of small coronary arteries (internal diameter averaged 100-150 μm) to H 2 O 2 , adenosine, and acetylcholine. In arterioles isolated from Kv1.5 −/− mice, vasodilation to H 2 O 2 was significantly lower than that in WT mice. Re-expression of Kv1.5 channels in smooth muscle (Kv1.5 −/− -RC after 7 days of doxycycline) increased H 2 O 2 -induced dilation to levels comparable to WT, and significantly greater than Kv1.5 −/− (P<0.05). Dilation to adenosine or to acetylcholine was not different between the WT and Kv1.5 −/− mice. Normal dilation to adenosine and to acetylcholine shows that the impaired vasodilation in Figure 3 . Relationship between double product (DP, mean arterial pressure×heart rate) and myocardial blood flow (MBF). MBF and DP were measured at baseline (5-10 min after hexamethonium) and during norepinephrine administration (0.5-5.0 μg/kg per minute IV). In Kv1.5 −/− mice, MBF was significantly lower compared with that in WT mice at any given dose of norepinephrine (NE; ♣, P<0.05). In Kv1.5 −/− double transgenic mice (Kv1.5 −/− -RC) treated with doxycycline, MBF was comparable to that in WT mice at all levels of DP (♦, P=NS Kv1.5 −/− -RC vs WT). MBF in Kv1.5 −/− -RC mice was significantly higher compared with that in Kv1.5 −/− mice (*, P<0.05). RC indicates reconstituted.
Kv1.5 −/− mice is not as a result of a nonspecific alteration of smooth muscle or the endothelium in the null mice. We also evaluated the vasoactive effects of norepinephrine, which did not produce constriction in these vessels (data not shown). This observation is similar to what we have observed previously in other species 25, 26 where coronary resistance vessels do not respond directly to α-adrenergic agonists. This latter observation is critical because it could be argued that the blunted metabolic dilation in Kv1.5 −/− mice during the norepinephrine stress test is caused by augmented adrenergic constriction; however, this was not the situation.
Discussion
In this study, we observed that Kv1.5 channels in smooth muscle play a key role in connecting MBF to cardiac metabolism. This observation was based on impaired increases in MBF during increased CW in Kv1.5 −/− mice. This inadequate dilation during increased CW was associated with severe tissue hypoxia and decrements in cardiac function, suggesting that oxygen delivery was not being correctly matched to oxygen consumption. We also found that the phenotype of impaired metabolic dilation could be rescued by re-expressing Kv1.5 channels in VSMCs, supporting the concept that the expression of the potassium channels in smooth muscle is critical for metabolic flow control. Taken together, these results support the conclusion that Kv1.5 channels play a key role in coronary metabolic dilation, that is, the connection of MBF to cardiac metabolism. We will discuss this conclusion from the perspective of the importance of the coronary microcirculation in health and disease, results in the literature that are cogent to our findings, and implications of our findings in understanding the control of coronary blood flow.
Importance of the Coronary Microcirculation in Health and Disease
The microcirculation of the heart comprises the bulk of vascular resistance 27 and is the segment most responsive to locally produced vasoactive metabolites. [28] [29] [30] Because of these attributes, under physiological conditions, the coronary microcirculation is the element of the coronary circulation most responsible for the dilation of blood vessels that occurs during increases in cardiac blood flow-the connection of flow to metabolism. Derangements in this connection can have undesirable consequences on cardiac function in that the myocardium requires a continual supply of oxygen for energy production.
Perhaps one of the more important implications of our study is shown in Figure 2C -2E. Figure 2D illustrates the outcome when flow, and thus, oxygen delivery, is uncoupled from CW (oxygen demands). Cardiac pump function and arterial pressure cannot be sustained during the metabolic stress because there is insufficient flow to meet the metabolic requirements of the heart. The decrease in pressure and pump function does not occur instantly when demands are increased by norepinephrine, but happens ≈30 s after norepinephrine induced the initial increase in arterial pressure. Note, in WT mice ( Figure 2C ) or in mice with smooth muscle-specific expression of Kv1.5 channels on the null background (Kv1.5-RC; Figure 2E ), arterial pressure was maintained during the entire period of norepinephrine infusion, indicating that the oxygen supply matched oxygen demands. In support of this concept, that in the Kv1.5 null mice, flow was uncoupled from metabolism, tissue hypoxia occurred in the null mice during the norepinephrine stress test (Figure 4 ; Online Figure VIII) , but tissue oxygenation was sustained at basal levels in WT and Kv1.5-RC mice. The maintenance of myocardial PO 2 indicates that oxygen consumption was matched to oxygen delivery, whereas a decrease in PO 2 suggests that flow and oxygen delivery were inadequate to meet the needs of the working heart. We also will add that the myocardial PO 2 's were higher than what we expected. Perhaps this is because of the placement of the crystals, which are injected in the LV free wall. We cannot eliminate the possibility that some portion of the signal arises from the LV lumen (perhaps some crystals are close to the lumen); however, despite this limitation, the Kv1.5 null mice show a different response to metabolic stress with decreases in PO 2 , which would not happen if a large portion of the signal arose from oxygenated blood in the LV lumen. Another caveat is that we are not claiming that norepinephrine produces tissue hypoxia in a WT animal, which could be inferred from the results in Online Figure VIII . The presence of hypoxic tissue could be an artifact of the tissue harvesting and processing, in which there are brief periods of time when the tissue is not perfused, and such a period could result in the appearance of hypoxia, when in fact during perfusion there was none. Nevertheless, even with this hindrance, we would like to emphasize that this would occur in both samples and would not be an explanation for why myocardial tissue hypoxia was more severe in the Kv1.5 −/− mice compared with the WT mice.
We think that our observations facilitate an understanding of microvascular disease in the heart. There have been several clinical indications; for example, the Women's Ischemia Syndrome Evaluation (WISE) trial has revealed that women, without large-vessel disease, show symptoms consistent with myocardial ischemia when stressed. [31] [32] [33] Also these women show abnormal coronary vasodilator reserve to adenosine. 34 On the surface, results from the WISE trial would seem inconsistent with our observations that adenosine-induced vasodilation was comparable in isolated coronary arterioles from WT and Kv1.5 −/− mice. We think that it is difficult to compare in vivo and in vitro responses to an agonist; considering the WISE trial studied patients with ischemic heart disease. In the Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb (GUSTO IIb) trial, it was reported that in patients with acute coronary syndromes, 30.5% of women with unstable angina and 10.2% of women with STEMI (ST segment elevation myocardial infarction) had normal coronary angiographies. 35 Moreover, a recent analysis has further supported the importance of microvascular disease in the heart; specifically, patients without large-vessel disease but with compromised coronary vasodilator reserve had mortality rates equivalent to those with large-vessel disease. 36 It is worth emphasizing that we are not concluding that Kv1.5 channels are the basis for microvascular disease in the human heart (also termed nonobstructive coronary disease); rather, we speculate that they may be. More likely, there may be several genetic polymorphisms, perhaps in different combinations, involved in nonobstructive coronary disease, which may be analogous to a condition like Long QT Syndrome, where many known polymorphisms of ion channels are known to cause the condition. 37 Previously, polymorphisms in several ion channels and in eNOS (endothelial nitric oxide synthase), but not in Kv1.5 channels, were associated with coronary microvascular disease. 38 We would like to speculate about an implication of our results that may also bear on clinical observations in patients with nonobstructive coronary disease. For example, in mice null for Kv1.5 channels, cardiac function as defined by measurements of EF and fractional shortening were less than in WT mice even during basal conditions (Online Figure IX) . Perhaps the disassociation of flow from metabolism induces mild cardiac dysfunction under basal conditions, which becomes more evident during a stress test. We speculate that in patients with nonobstructive coronary disease, the higher incidence of cardiovascular complications relates to insufficient blood flow to the myocardium. 39
Considerations From the Literature
The factors and the effectors responsible for coronary metabolic dilation have remained elusive. Historically, adenosine was considered to be the metabolite linking coronary blood flow to oxygen consumption, 40, 41 but this hypothesis was rigorously challenged by estimates of interstitial adenosine concentrations that are insufficient to produce dilation during increased CW. 42, 43 Although some pharmacological studies show an involvement of adenosine in metabolic dilation when other mechanisms of dilation are blocked, 44 this may be more of the result of ischemic dilation as opposed to an aerobic process linking work to metabolism. Other efforts have suggested a role for K ATP channels and the K Ca channels in coronary metabolic dilation, 45, 46 but it is important to point out that a limitation of such work is the exquisite reliance on pharmacological approaches to draw conclusions about particular ion channels. Moreover, other work has challenged the role of K ATP channels in local coronary metabolic dilation. 43, 47, 48 More recently, the role of ATP released by red blood cells was postulated, 49, 50 but this hypothesis requires endothelial production of nitric oxide, which has been found to be not essential for coronary metabolic hyperemia. 43 Indeed, our present results bear on these previous findings in that responses to adenosine and to nitric oxide were not affected in the Kv1.5 null mice; yet coronary metabolic dilation was severely compromised in these mice. These observations are in concordance with previous studies, concluding that neither adenosine nor nitric oxide is critically involved in coronary metabolic dilation.
Previously, we proposed that mitochondrial production of H 2 O 2 is a feed-forward link between metabolism and flow in the heart. 18 We further established that the vasodilatory actions of H 2 O 2 were redox-dependent 19 and mediated by 4-aminopyridine-sensitive ion channels. 17 Although it is reasonable to speculate that 4-aminopyridine-sensitive ion channels are Kv channels, it is presumptuous to make this conclusion only on the basis of pharmacological evidence. September 11, 2015
The current state of knowledge linking specific ion channels to metabolic dilation in the heart is primarily based on the use of pharmacological agents, for example, tetraethylammonium to block MaxiK channels, 46 glibenclamide to block K ATP channels, 45 and 4-aminopyridine to block all Kv channels. 18, 51 In these experiments, the antagonists were used to attenuate coronary metabolic dilation to exercise, administration of inotropes, and pacing in anesthetized dogs. Definitive conclusions are limited, however, because of the relative nonspecificity of the ion channel antagonists. For example, tetraethylammonium blocks virtually any K channel, 20, 52, 53 and glibenclamide antagonizes both the sarcolemmal K ATP channel and the mitochondrial K ATP channel, [54] [55] [56] as well as Kv channels. 53, 57 In addition to blocking Kv channels, 4-aminopyridine also can antagonize K ATP channels. 20 Accordingly, we opine that conclusions about a specific ion channel transducing metabolic signals into changes in coronary blood flow is based on experiments using traditional pharmacological responses are premature. What is clear from the literature is the 4-aminopyridine-sensitive ion channels are involved in the coronary metabolic dilation, 18, 51 but the identity of the specific channel is not revealed by these previous studies. Although several types of Kv family channels are expressed by various cells in the heart, we focused on Kv1.5 channels because their oxygen and redox sensitivity [21] [22] [23] makes them likely candidates to mediate metabolic dilation.
Implications of Kv1.5 Channels in the Control of Coronary Blood Flow and Vascular Tone
Our results are consistent with the concept that Kv1.5 channels are directly involved in coronary metabolic dilation and play a role in the link between MBF and cardiac metabolism. Before we discuss evidence supporting this conclusion, we would like to emphasize that we do not think this ion channel is the only effector modulated by metabolites that connects flow to metabolism. If it was, then we would expect the knockout to be lethal, but this is not the observation. Although there were modest changes in MBF at rest between the Kv1.5 −/− mice and WT mice, this difference was insufficient to affect basal cardiac function; however, when the null mice were subjected to a metabolic stress (induced by norepinephrine), the increase in MBF (metabolic dilation) was insufficient to sustain cardiac function as indicated by acute decreases in cardiac function and the development of profound tissue hypoxia (Figures 2D,  3 , and 4, respectively). In contrast, WT mice subjected to the same metabolic stress maintained cardiac function, and the appropriate metabolic dilation maintained tissue oxygenation during the duration of the increased metabolic demands.
An important implication of our results is that in addition to the Kv1.5 channels, other mechanisms of vasodilation must play a role in the metabolic control of the coronary circulation. There are several observations supporting this statement. First, knockout of Kv1.5 channels was not lethal. If Kv1.5 channels were the only connection between metabolism and flow in the heart, we would expect lethality in a knockout because cardiac function cannot be sustained by anaerobic metabolism. Second, we observed a connection, albeit blunted, between CW and coronary blood flow in the Kv1.5 null mice. Accordingly, there must be other mechanisms involved in coronary metabolic dilation. Third, responses to the coronary metabolic dilator, H 2 O 2 , were not completely abolished in the Kv1.5 null mice. Taken together, these results imply that other mechanisms, eg, different redox-sensitive ion channels, 59 ion channels modulated directly by oxygen, 60 and/or other redox-dependent signaling processes, eg, dimerization of protein kinase G, 61 compensate for the loss of the Kv1.5 channel control mechanism. Finally, the knockout of the Kv1.5 channels was associated with an upregulation of Kv1.2, Kir6.1, and Kir6.2 channels (Online Figure VII) , which may compensate for the loss of this membrane ion channel through their control of both smooth muscle membrane potential and vascular tone. 59, 61 A potential criticism of our study design is that we used mice with global knockout of Kv1.5 channels in the study of coronary metabolic dilation. Because these channels are located in many cell types, for example, cardiac myocytes, 62, 63 endothelial cells, 64, 65 and neurons, 66 it could be argued that the effects observed in the global knockout can be attributed to cell types other than vascular myocytes. Although a cell-specific knockout would have provided cogent information, given our results that the re-expression of the channel in smooth muscle on the null background rescued the phenotype, it is likely that our conclusions would be the same, that is, the importance of the Kv1.5 channel in facilitating the connection between coronary blood flow and myocardial metabolism. It is worth noting that our model of conditional (Tet-On) expression of the channel would not cause developmental compensations as would permanent knockout of the channel-even in a cellspecific manner. These results build on our previous results, suggesting that the H 2 O 2 is a metabolic dilator in the heart, in that small arteries isolated from the null mice showed blunted dilation to this reactive oxygen species (compared with WT mice), and doxycycline-inducible expression of Kv1.5 channels in smooth muscle restored this vasodilation. It is also worth noting that vessels from the null mice did not show any response to norepinephrine, so the blunted metabolic dilation during the norepinephrine stress test should not be interpreted as possible enhanced constriction to this adrenergic agonist.
Another possible explanation is that the deletion of Kv1.5 channels in cardiac myocytes renders them more responsive to the production of vasoconstrictors when stimulated by adrenergic agonists. This possibility is founded on previous work from our laboratory showing that stimulation of adrenergic receptors in cardiac myocytes results in the production of a substance or substances that mediate coronary arterial vasoconstriction. 25, 26 However, we do not think this explanation is plausible given that re-expression of the Kv1.5 channels only in smooth muscle restored MBF during the norepinephrine stress test.
The application of contrast echocardiography to measure MBF was described over 2 decades ago, 67 and since this observation, the technique has been used to measure blood flow in a variety of animal models 68, 69 and in the clinical setting. [70] [71] [72] One advantage of this technique is the ability to measure blood flow in vivo under minimally invasive conditions (intravenous catheter for contrast infusion). Previous measurements of MBF in the mouse heart were confined to buffer-perfused isolated heart models, [73] [74] [75] [76] which impact a variety of control mechanisms for coronary blood flow, causing concerns about physiological relevance of the observations. In our study, we used contrast echocardiography to measure MBF in anesthetized mice, and these values were ≈40% higher compared with the flows measured with microspheres. Raher et al 77 compared microsphere measurements of flow to those obtained with contrast echocardiography and similar to our results found a strong correlation between the 2 measurements. Although the slope of their linear regression was close to identity, they did not quantify blood flow and left the myocardial contrast echocardiography measurement in units of db/s. Therefore, it is difficult to relate our comparison of blood flows derived from myocardial contrast echocardiography and microspheres to theirs. Magnetic resonance imaging was used to measure myocardial perfusion in a murine model, and these investigators reported baseline flows in the range of 7 mL/min per gram. 78 This range was less than our myocardial contrast echocardiography measurements of ≈12 mL/min per gram at baseline, but if we corrected based on the microsphere measurements, our values would be comparable. Our values, especially those at the highest dose of norepinephrine, were higher than what we expected, but similar to the highest values in buffer-perfused, isolated hearts (Online Figure X) . We have not corrected the blood flow measurements that we report, but wish to emphasize that any adjustment in the measurement would not change the most important aspect of our study-the impairment in metabolic dilation in Kv1.5 −/− mice and restoration of flows in the Kv1.5 −/− -RC mice. After correction, MBF values for all mice would be decreased by a certain factor, and the differences would remain the same.
Conclusions
In the heart, vascular Kv1.5 channels play a critical role in coupling MBF to cardiac metabolism. This coupling is critical in the maintenance of tissue oxygenation during hemodynamic challenges through balancing oxygen delivery via metabolic coronary dilation and oxygen consumption via CW.
